1 韩涛,丁劲,王红阳.β-catenin信号分子的生物学功能及其在肝癌中的研究进展[J].中国生物工程杂志,2011,31(9):96-102. 2 Zhao XT,Liu FZ,Zhang Y,et al.Prognostic and clinicopathological significance of Gankyrin overexpression in cancers:evidence from a meta-analysis[J].Onco Targets Ther,2016,9:1961-1968. 3 Jing HB,Zhang GM,Meng LS,et al.Gradually elevated expression of Gankyrin during human hepatocarcinogenesis and its clinicopathological significance[J].Sci Rep,2014,4:5503. 4 Zhao X,Fu J,Xu A,et al.Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway[J].Cell Death Dis,2015,6(5):1751-1761. 5 Liu L,Zhu XD,Wang WQ,et al.Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis[J].Clin Cancer Res,2010,16(10):2740-2750. 6 Kaidi A,Williams AC,Paraskeva C.Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia[J].Nat Cell Biol,2007,9(2):210-217. 7 Wang D,Wang Y,Kong T,et al.Hypoxia-induced β-catenin downregulation involves p53-dependent activation of Siah-1[J].Cancer Sci,2011,102(7):1322-1328. 8 Hoogeboom D,Essers MA,Polderman PE,et al.Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity[J].J Biol Chem,2008,283(14):9224-9230. 9 金世龙,刘宏鸣,刘宝华,等.肝癌细胞β-catenin表达及其亚细胞内分布[J].中华肝胆外科杂志,2007,13(9):632-634. 10 刘亮,徐华祥,王文权,等.肝动脉断流促进癌旁正常肝细胞上皮-间质转化[J].中华实验外科杂志,2011,28(10):1643-1645. 11 Evdokimova V,Tognon C,Ng T,et al.Reduced proliferation and enhanced migration:two sides of the same coin? Molecular mechanisms of metastatic progression by YB-1[J].Cell Cycle,2009,28(8):2901-2906. 12 Fu J,Chen Y,Cao J,et al.p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via PI3K/AKT/HIF-1α pathways[J].Hepatology,2011,53(3):181-192. 13 Dai RY,Chen Y,Fu J,et al.p28GANK inhibits endoplasmic reticulum stress-induced cell death via enhancement of the endoplasmic reticulum adaptive capacity[J].Cell Res,2009,19(6):1243-1257. 14 Tan L,Fu XY,Liu SQ,et al.Expression of p28GANK and its correlation with RB in human hepatocellular carcinoma[J].Liver International,2005,25(4):667-676. 15 De La CA,Romagnolo B,Billuart P,et al.Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas[J].Proc Natl Acad SciUSA,1998,95(12):8847-8851. 16 Suzuki T,Yano H,Nakashima Y,et al.Beta-catenin expression in hepatocellular carcinoma:a possible participation of beta-catenin in the dedifferentiation process[J].J Gastroenterol Hepatol,2002,17(3):994-1000. 17 Wong CM,Fan ST,Ng IO.Beta-catenin mutation and over-expression in hepatocellular carcinoma:clinicopathologic and prognostic significance[J].Cancer,2001,92(21):136-145. 18 Higashitsuji H,Higashitsuji H,Itoh K,et al.The oncoprotein gankyrin binds to MDM2/HDM2,enhancing ubiquitylation and degradation of p53[J].Cancer Cell,2005,8(3):75-87. 19 Dong LW,Guang ZY,Pan YF,et al.The oncoprotein p28GANK establishes a positive feedback loop in β-catenin signaling[J].Cell Res,2011,21(8):1248-1261. |